8-K: Xenetic Biosciences, Inc. Reports Third Quarter 2024 Financial Results
10-Q: Q3 2024 Earnings Report
8-K: Current report
EFFECT: Others
8-K: Current report
ARS: Annual Report to Security Holders
DEFA14A: Others
DEF 14A: Definitive information statements
CORRESP: CORRESP
UPLOAD: Others
S-3: Registration statement for specified transactions by certain issuers
8-K: Xenetic Biosciences, Inc. Reports Second Quarter 2024 Financial Results and Provides Business Update
10-Q: Q2 2024 Earnings Report
25-NSE: Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities (and amendment thereto)
4: Statement of changes in beneficial ownership of securities-Officer PARSLOW JAMES F
8-K: Current report
8-K: Current report
8-K: Xenetic Biosciences, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update
10-Q: Q1 2024 Earnings Report
10-K/A: Annual report (Amendment)